Prescribed Specialised Services Advisory Group

Health written question – answered on 11th June 2014.

Alert me about debates like this

Photo of Peter Aldous Peter Aldous Conservative, Waveney

To ask the Secretary of State for Health

(1) how often the Prescribed Specialised Services Advisory Group meets per year; and if he will request that it will consider new specialised service applications for alpha 1-antitrypsin deficiency at its next meeting;

(2) what steps NHS England takes to consider (a) all new specialised service applications and (b) new treatments for alpha 1-antitrypsin deficiency; and whether such steps are subject to review by his Department.

Photo of Norman Lamb Norman Lamb The Minister of State, Department of Health

The Prescribed Specialised Services Advisory Group (PSSAG) is a Department expert committee which was set up to provide regular advice to Ministers on which services are specialised and should be prescribed in regulations for national commissioning by the NHS Commissioning Board (NHS England). The Group met most recently in May 2014 and may meet up to four times a year.

Evidence, supporting information and activity on those services currently prescribed in legislation for direct commissioning by NHS England and any new services identified as potentially specialised, are made available to PSSAG from a range of sources, which may include Clinical Reference Groups (CRGs), patient groups, clinicians, commissioners and members of the public. The proposals the group considers are in large part generated by NHS England through its CRGs. The PSSAG makes recommendations to Ministers who, before deciding whether to make regulations, consult with NHS England, as required by section 3B of the National Health Service Act 2006.

NHS England advises that where it becomes the responsible commissioner for a service, it considers the funding priority of the service through its clinical priorities advisory group and manages a process for selecting providers. Any highly specialised services that become the commissioning responsibility of NHS England will be discussed at its Rare Disease Advisory Group.

The commissioning of services for people with alpha 1-antitrypsin deficiency is a matter for individual clinical commissioning groups. We understand the Alpha 1 Alliance is working with NHS England and the Specialised Respiratory Clinical Reference Group to develop a proposal on alpha 1-antitrypsin deficiency for a future PSSAG meeting.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.